Pharmacognosy Magazine

ORIGINAL ARTICLE
Year
: 2022  |  Volume : 18  |  Issue : 77  |  Page : 29--35

Anticarcinogenic effect of brucine on DMBA-induced skin cancer via regulation of PI3K/AKT signaling pathway


Jie Wang1, Zhenxing He2, Juhua Zhao1, Wenming Xiao3, Lingling Xiong1, Wei Chen4 
1 Department of Dermatology, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong 637000, Sichuan, China
2 Department of Hepatobiliary Surgery, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong 637000, Sichuan, China
3 Chongqing Vcham Plastic Surgery Hospital Ltd, Jiangbei district Chongqing, 400020, Chongqing, China
4 Department of Pathophysiology, Basic Medical School, North Sichuan Medical College, Nanchong 637500, Sichuan, China

Correspondence Address:
Wei Chen
Department of Pathophysiology, Basic Medical School, North Sichuan Medical College, Nanchong 637100, Sichuan
China

Background: Brucine is an alkaloid derived from the natural plant seeds of Strychnos nux-vomica, also known as a medicinal herb, and broadly employed in Chinese medicine for liver cancer. Objectives: The main intention of these hypothesis anticancer effects of brucine on 7,12-dimethylbenz(a)anthracene (DMBA)-induced skin cancer in mouse model through phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) regulating signaling pathway via the suppressive effect on cell proliferation and apoptotic pathways in mouse model. Materials and Methods: Brucine action on DMBA-induced mouse skin body weight, tumor volume, histology, biochemical, molecular marker analysis using spectrophotometric, Western blotting, and real-time polymerase chain reaction analysis. Results: Brucine stifled the lipid peroxidation (TBARS), suggestively augmented the levels of antioxidants (superoxide dismutase, catalase, glutathione peroxidase, and glutathione), and brought back the status of xenobiotic enzymes (Cyt-p450, Cyt-b5, and glutathione S-transferases). In brucine administered since skin tissues presented the cell proliferative protein marker expression of PI3K, and AKT were downregulated compared to the DMBA-applied skin tumor tissues protein. Further, brucine has downregulated the proliferating cell nuclear antigen, cyclin-D1, and p53 expressions. In the apoptotic expression, markers such as Bcl-2, Bax, caspase-3, and caspase-9 were upregulated compared to the DMBA-induced skin cancer. From these data, we diseased and brucine potential to suppress the proliferative cell markers induces apoptotic expressions. Conclusion: The current search settled that administering brucine chemopreventive and chemotherapeutic effect means for the cancer management in clinical tactic.


How to cite this article:
Wang J, He Z, Zhao J, Xiao W, Xiong L, Chen W. Anticarcinogenic effect of brucine on DMBA-induced skin cancer via regulation of PI3K/AKT signaling pathway.Phcog Mag 2022;18:29-35


How to cite this URL:
Wang J, He Z, Zhao J, Xiao W, Xiong L, Chen W. Anticarcinogenic effect of brucine on DMBA-induced skin cancer via regulation of PI3K/AKT signaling pathway. Phcog Mag [serial online] 2022 [cited 2022 Dec 6 ];18:29-35
Available from: http://www.phcog.com/article.asp?issn=0973-1296;year=2022;volume=18;issue=77;spage=29;epage=35;aulast=Wang;type=0